Attached files
| file | filename |
|---|---|
| 10-Q - Targeted Medical Pharma, Inc. | v223729_10q.htm |
| EX-31.1 - Targeted Medical Pharma, Inc. | v223729_ex31-1.htm |
Exhibit 32.1
CERTIFICATION
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Targeted Medical Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: May 23, 2011
|
By:
|
/s/ William E. Shell, MD
|
|
William E. Shell, MD
Principal Executive Officer and Principal Financial Officer
|